XML 84 R73.htm IDEA: XBRL DOCUMENT v3.5.0.2
(LOSS) EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Earnings Per Share [Abstract]        
Net (loss) income attributable to Valeant Pharmaceuticals International, Inc. $ (302.3) $ (53.0) $ (676.0) $ 44.7
Basic weighted-average number of common shares outstanding (in shares) 345.0 344.4 344.9 340.5
Diluted effect of stock options, RSUs and other (in shares) 0.0 0.0 0.0 6.6
Diluted weighted-average number of common shares outstanding (in shares) 345.0 344.4 344.9 347.1
(Loss) earnings per share attributable to Valeant Pharmaceuticals International, Inc.:        
Basic (in usd per share) $ (0.88) $ (0.15) $ (1.96) $ 0.13
Diluted (in usd per share) $ (0.88) $ (0.15) $ (1.96) $ 0.13